Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adul... von Lee, Andrew W, Liu, Ken, Lhomme, Edouard, Blie, Julie, McCullough, John, Onorato, Matthew T, Connor, Laurie, Simon, Jakub K, Dubey, Sheri, VanRheenen, Susan, Deutsch, Jonathan, Owens, Abigail, Morgan, Amy, Welebob, Carolee, Hyatt, Donna, Nair, Sunita, Hamzé, Benjamin, Guindo, Oumar, Sow, Samba O, Beavogui, Abdoul H, Leigh, Bailah, Samai, Mohamed, Akoo, Pauline, Serry-Bangura, Alimamy, Fleck, Suzanne, Secka, Fatou, Lowe, Brett, Watson-Jones, Deborah, Roy, Céline, Hensley, Lisa E, Kieh, Mark, Coller, Beth-Ann G

Volltext

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases von Wiedemann, Aurélie, Lhomme, Edouard, Huchon, Mélanie, Foucat, Emile, Bérerd-Camara, Marion, Guillaumat, Lydia, Yaradouno, Marcel, Tambalou, Jacqueline, Rodrigues, Cécile, Ribeiro, Alexandre, Béavogui, Abdoul Habib, Lacabaratz, Christine, Thiébaut, Rodolphe, Richert, Laura, Lévy, Yves

Volltext